Skip to main content

Prematurely delivering mothers show reductions of lachnospiraceae in their gut microbiomes



Preterm birth is the leading cause of perinatal morbidity and mortality. Despite evidence shows that imbalances in the maternal microbiome associates to the risk of preterm birth, the mechanisms underlying the association between a perturbed microbiota and preterm birth remain poorly understood.


Applying shotgun metagenomic analysis on 80 gut microbiotas of 43 mothers, we analyzed the taxonomic composition and metabolic function in gut microbial communities between preterm and term mothers.


Gut microbiome of mothers delivering prematurely showed decreased alpha diversity and underwent significant reorganization, especially during pregnancy. SFCA-producing microbiomes, particularly species of Lachnospiraceae, Ruminococcaceae, and Eubacteriaceae, were significantly depleted in preterm mothers. Lachnospiraceae and its species were the main bacteria contributing to species’ differences and metabolic pathways.


Gut microbiome of mothers delivering prematurely has altered and demonstrates the reduction of Lachnospiraceae.

Peer Review reports


Preterm birth (PTB) is defined as birth before 37 weeks. Fifteen million infants were born preterm worldwide, which puts these children at risk of morbidity and mortality or long-term health problems [1, 2]. Complications of PTB were the leading cause of death among children under five years [3]. The potential lifelong impact lasts into adolescence and even adulthood, affecting their motor, learning abilities, mental health, and social functioning [4, 5].

The etiology of PTB is still unclear. There is consensus that PTB is a syndrome involving multiple biological pathways [6]. The pro-inflammatory cytokines, especially interleukin-1 (IL-1) are known to contribute to inflammation-induced PTB critically [7]. While Maternal-fetal genetics and immunity have provided substantial insights into the molecular mechanism of PTB [8], accumulating evidence indicates that the host gut microbiome regulates maternal and fetal immune interaction and directly affects the birth outcome [9]. The dysbiosis of the maternal microbiome affects metabolism and inflammatory processes through microbiome-generated metabolites, which may induce the PTB [10]. The association between vaginal [11], oral microbiome [12] with PTB has been widely reported. An intrauterine infection ascending from the vagina is widely characterized as an important contributor to the onset of preterm labour. The vaginal microbiome of women who delivered term is dominated by Lactobacillus during pregnancy [13]. In contrast, women who delivered preterm exhibited significantly lower vaginal levels of Lactobacillus[14]. Depletion of Lactobacillus species and a more diverse vaginal microbiome leads to increased mannose binding lectin, IgM, IgG, C3b, C5, IL-8, IL-6, IL-1β and increased risk of PTB [15]. Haematogenous dissemination of microbes from oral cavity has also been proposed as another potential route of infection leading to PTB [12]. However, despite a number of observational studies show an increased risk of PTB in women with periodontitis diseases, the evidence behind it is still weak [16, 17].

We know little about the potential interaction effects of the maternal gut microbiome on PTB. Only a few studies identified the distinct gut microbiome in preterm mothers. Shiozaki et al. [18] showed a reduction of several species from Clostridium and Bacteroides were observed in the gut of mothers delivering prematurely. Cecilie Dahl et al. [19] found that mothers of preterm deliveries show reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus. In a recent study, Chunhua Yin et al. [20] reported that gut microbiome of patients who deliver preterm contains higher common oral bacteria. While these studies were provided by 16 S rRNA. Shotgun metagenomics improves the ability to discriminate microbiome at a species-level, or even strain-level, and allows accurate functional annotation of the gene sequences [21]. Compared to previous articles, our study performed shotgun metagenomic sequencing to identify a greater number of genera. A total of 765 genera were detected, and in addition, 575 distinct species were identified at the species level. Thus, high-resolution metagenomic studies are required to examine the impact of disrupted gastrointestinal bacteria in the maternal gut on the PTB.

Here, we perform a metagenomic analysis to identify the taxonomic composition and metabolic function in gut microbial communities between preterm and term mothers. We also explore how the maternal gut microbiome may contribute to PTB progression.


Subject recruitment and sample collection

This study was approved by the Ethical Committee of the West China Second Hospital of Sichuan University (2,021,112). Informed written consent was obtained from all the participants. Forty-three mothers were recruited at the West China Second Hospital of Sichuan University from December 2020 to December 2021. We excluded mothers with metabolic diseases, such as obesity, diabetes, hypertension, and hyperuricemia, and mothers with immune diseases, such as rheumatoid arthritis, lupus erythematosus, Hashimoto’s thyroiditis, and ulcerative colitis. We also excluded mothers who do not want to participate in the study or withdraw from the study.

Before sample collection, we explained the collection precautions to the mothers in detail. We sampled the mother’s fecal samples during the last week of pregnancy and one month after delivery. Samples collected in the hospital were immediately sent to the laboratory and frozen at -20 ℃, then transferred to store at − 80 ℃ within 24 h. The samples collected at home were shipped to the laboratory in West China Second Hospital of Sichuan University within 2–3 days, then the samples were stored at -80℃. The instruction of stool collection tubes (Shbio scRNA-seq Kit, shanghai, china) showed the samples could store at room temperature for 14 days (

Fecal genomic DNA extraction and sequencing

The microbial community DNA was extracted using QIAamp PowerFeacal Pro DNAKit (QIAGEN, 51804, USA) following the manufacturer’s instructions. DNA concentration was measured using a NanoDrop spectrophotometer (Thermo Fisher Scientific, USA) and Qubit Fluorometer (Invitrogen, USA). All extracted DNA samples were stored at − 80°C until shotgun metagenomic sequencing. We did negative controls in the same way as the actual samples. DNA was randomly fragmented by Covaris. The fragmented DNA was selected by Magnetic beads to an average size of 200–400 bp. The selected fragments were through end-repair, 3’ adenylated, adapters-ligation, and PCR Amplifying, and the products were purified by the Magnetic beads. The double-stranded PCR products were heat denatured and circularized by the splint oligo sequence. The single-strand circle DNA (ssCir DNA) was formatted as the final library and qualified by QC. Paired-end sequencing was performed on the DNBSEQ-T7 platform (BGI-Shenzhen, China) with an insert size of 350 bp and paired-end (PE) reads of 150 bp, targeting ~ 10 Gb of sequence per sample.

Quality control

We performed quality control of the sequencing data using KneadData ( with default parameters. Adapters were removed and reads with low quality bases were trimmed (windows: 4-mer, Phred quality < 20) and truncated (< 50% of pre-trimmed length) using Trimmomatic (version = 0.39). The filtered paired-end reads were mapped to the human genome (hg19, GCA_000001405.1) using bowtie2 (version = 2.3.1) with default parameters (--very-sensitive) to eliminate potential human contamination.

Taxonomy annotation and functional annotation

Taxonomic and functional profiling of metagenomic sequencing data was performed with the wmgx bioBakery workflow built with AnADAMA2 [22] ( Taxonomic profiling was conducted using MetaPhlAn3 (version = 3.0.14) with the default parameters. Functional profiling was performed by HUMAnN3 (version = 3.0.1) with the default parameters. The CHOCOPhlAn (release 2019.01) database was used for taxonomy and functional annotation, whereas the UniRef90 database (release 2021.03) was used for gene family abundance determination.

Bioinformatics analysis

We used Wilcoxon rank-sum test to compare demographics characteristics between groups. The ‘amplicon’ R package (Version: 3.5.3) was used to visualize the rarefaction curve. We used the Gutmeta website ( to visualize the richness and evenness of the gut microbiome composition with the Shannon index. We used principal coordinates analysis (PCoA) of binary Bray-Curtis distance to evaluate the gut microbiota from different groups, which was calculated by USEARCH. We conducted PERMANOVA with Bray-Curtis distance using the ‘adonis’ function from the ‘vegan’ R package (Version: 3.5.3). The ‘ggplot2’ package (Version: 3.5.3) was used to visualize the relative abundance of phylum, genus, and species levels. The potential biomarkers were assessed with the LEfSe method. The effect size of differentially abundant genera was estimated by linear discriminant analysis (LDA)[23]. The LDA score > 2.0 and p-value < 0.05 were considered as statistically significant. Statistical Analysis of Metagenomic Profiles (STAMP) software was used to conduct significantly different bacteria between groups with Wilcoxon [24]. HUManN2-associated module was used to identify differentially functional pathways. All the p values were adjusted by False Discovery Rate (FDR) and q-values < 0.05 were considered as statistically significant.


Study population

To interrogate the composition and function of the gut microbiome between preterm mothers (PMs) and term mothers (TMs), we enrolled 43 mothers with 33 TMs and 10 PMs. During the last week of pregnancy, we collected 28 TMs and 9 PMs, and one month after delivery, we collected 33 TMs and 10 PMs. The demographic information of the participants is presented in Table 1. No significant differences were observed in maternal age, pregnancy weight, and prenatal BMI between the TMs and PMs groups (Table 1; P > 0.05). There was a significant difference in gestational age and birth weight between the two groups, with the PMs group showing a lower total score compared to the TMs group (Table 1; P < 0.001). The Rarefaction Curve showed that the curve tends to be flat as the sequencing depth increased, which indicated the sequencing depth is sufficient (Fig. 1).

Table 1 Clinical characteristics of TMs and PMs
Fig. 1
figure 1

Rarefaction Curve

Distinct gut microbial communities in PM

We first analyzed the alpha diversity of communities at different periods. During the last week of pregnancy, there was no difference in alpha diversity at the phylum level (p > 0.05). However, the alpha diversity was decreased in the preterm group at the genus and species levels (p < 0.01). After delivery, no discernable differences between the two groups, either at phylum, gene level, or species level, were identifiable (p > 0.05; Fig. 2A). These results indicate that a high richness and evenness in the TMs group and the gut of PMs altered in the third trimester of pregnancy but soon returned to the normal level after delivery. Beta-diversity was calculated using bray-Curtis distance metrics to measure the extent of similarity in fecal microbial communities (Fig. 2B). Principal coordinate analysis (PCoA) revealed separation of the two groups before (PERMANOVA, P = 0.011) and after delivery (PERMANOVA, P = 0.013). The analysis indicated that the microbiome community of the PMs group was heterogeneous and significantly different from that of the TMs group.

Fig. 2
figure 2

Distinct Gut Microbial Communities in Mothers Delivering Prematurely. (A) Comparison of alpha diversity between the PMs and TMs groups at phylum, genus, and species level. (B) Principal coordinates analysis (PCOA) analysis between the PMs and TMs groups. (C) Relative abundances of gut microbiomes for PMs and TMs at phyla and species level

We next sought to understand how microbiome composition and developmental trajectory were altered. Mothers had a high fraction of Firmicutes and Bacteroidetes, as expected for a healthy China pregnancy gut. Compared with TMs, PMs showed an increase in Bacteroidetes and a decrease in Firmicutes, especially during pregnancy. We confirmed this observation on the species-level profiles. During pregnancy, TMs were dominated by species from the Bacteroides (28.3%) and Clostridia (23.3%). In contrast, there was a significant decrease of Clostridia (14.5%) in PMs, including Faecalibacterium prausnitzii, Fusicatenibacter saccharivorans, Anaerostipes hadrus, Ruminococcus torques and Ruminococcus bromii, and most of which were belonged to Lachnospiraceae (11.7%). The differences in microbial species between the two groups were reduced after delivery (Fig. 2C).

Significant reductions of SFCAs-producing microbiomes in mothers delivering prematurely

Linear discriminate analysis effect size (LEfSe) was also performed to corroborate representative taxa further. We performed LefSe analysis and identified 116 taxa showing significant differences (P < 0.05, LDA > 2), 92 taxa in TMs, and 24 in PMs (Fig. 3A, Supplementary Figure S1). The Lachnospiraceae, Ruminococcaceae, Eubacteriaceae, Prevotellaceae and members of these bacterium such as Faecalibacterium prausnitzii, Bacteroides. uniformis, Bacteroides. stercoris, Fusicatenibacter. saccharivorans, Bacteroides dorei, Anaerostipes hadrus, Ruminococcus bromii, Eubacterium eligens, Ruminococcus torques, and Blautia obeum were signature taxa for TMs. While PMs were characterized by the Bacteroidaceae, Erysipelotrichaceae, and Pasteurellaceae, such as Bacteroides thetaiotaomicron, Ruminococcus gnavus, Bacteroides vulgatus, Megamonas funiformis, Sutterella parvirubra, and Streptococcus infantarius. The results demonstrated that the communities of TMs were dominated by species from Lachnospiraceae, Ruminococcaceae, and Eubacteriaceae, which are efficient degraders of dietary fibers and producers of short-chain fatty acids (SCFAs). These SFCAs-producing species were deficient in the gut of PMs.

Fig. 3
figure 3

Significant reductions of SFCAs-Producing microbiomes in PMs. (A) LEfSe analysis of PMs and TMs groups. (B) Statistically significant different species in PMs and TMs groups

Given the differences of composition in the maternal gut metagenomes, we sought to validate the diversity of species between PMs and TMs in the gut microbiome (Fig. 3B). A total of seven different species were identified, including Fusicatenibacter saccharivorans, Dorea formicigenerans, Lachnospira pectinoschiza, Coprococcus comes, Eubacterium ventriosum, Dorea longicatena, and Faecalibacterium prausnitzii (p < 0.05). All of them belong to the Clostridia order. The Eubacterium ventriosum belongs to Eubacteriaceae, Faecalibacterium prausnitzii belongs to Ruminococcaceae, and the rest (71.4%, 5/7) belong to Lachnospiraceae.

Differential microbial functions in the gut microbiome between PMs and TMs

To assess whether the apparent taxonomic differences between the gut microbiomes of PMs and TMs are reflected at the level of functional potential, we compare the functional profiles of PMs to those of healthy mothers. Several pathways were over-represented in TMs (p < 0.05), including amino acid, adenosylcobalamin, molybdenum pterin, and starch metabolism pathways (Fig. 4A). We found that some different species were involved the inmolybdopterin biosynthesis pathway, the starch degradation III pathway, the superpathway of adenosylcobalamin salvage from cobinamide pathway, and the L-arginine biosynthesis IV pathway among these metabolic pathways, so the four metabolic pathways were further visualized (Fig. 4B).

Fig. 4
figure 4

Differential microbial functions in the gut microbiome between PMs and TMs. (A) Statistically significant differences in predicated metabolic pathways between PMs and TMs groups. (B) Visualization of different species involved in differential microbial functions

In the molybdopterin biosynthesis pathway, Faecalibacterium prausnitzii, Blautia obeum, Ruminococcus torques, Fusicatenibacter saccharivorans, Blautia wexlerae, Ruminococcus gnavus, Escherichia coli mainly contributed to this metabolism. Most of the bacterium belong to Lachnospiraceae, except the Faecalibacterium prausnitzii, which belongs to Ruminococcaceae. In the starch degradation III pathway, Blautia obeum, Blautia wexlerae, Fusicatenibacter saccharivorans, Escherichia coli, Eubacterium hallii, Roseburia inulinivorans, Ruminococcus torques mainly contributed to the pathway. Similarly, except Eubacterium hallii belongs to Eubacteriaceae, other species belong to Lachnospiraceae. In the superpathway of adenosylcobalamin salvage from cobinamide pathway, Faecalibacterium prausnitzii, Bacteroides uniformis, Escherichia coli, Blautia obeum, Blautia wexlerae, Ruminococcus torques, Bilophila wadsworthia contributed to the pathway, of which Blautia obeum, Blautia wexlerae, Ruminococcus torques belong to Lachnospiraceae. In the L-arginine biosynthesis IV pathway, Escherichia coli, Ruminococcus torques, Eubacterium hallii, Clostridium bolteae, Klebsiella pneumoniae, Coprococcus catus, Enterobacter cloacae complex contributed to the pathway. Ruminococcus torques, Coprococcus catus belong to Lachnospiraceae. These results indicate that Lachnospiraceae and its species were the main bacteria that contributed to the differential species and metabolic pathways in the gut of preterm mothers.


We collected fecal samples from preterm and term mothers, coupled with deep metagenomic sequencing, which allowed us to characterize these communities’ microbial composition and functions. We found that the gut microbiome of mothers delivering prematurely showed reduced alpha diversity and underwent significant reorganization, especially during pregnancy. Mothers delivering prematurely lacked species from Lachnospiraceae, Ruminococcaceae, and Eubacteriaceae, Lachnospiraceae, and its species were the main bacterium that contributes to the differential species and metabolic pathways in the gut of preterm mothers.

This is the first study comparing gut microbial communities between preterm and term mothers performing with shotgun metagenomics sequencing. A few studies have investigated the gut microbiome in preterm mothers performing 16 S rRNA amplicon sequencing. Shiozaki et al. [18] observed that the level of Clostridium subcluster XVIII, Clostridium cluster IV, and Clostridium subcluster XIVa were significantly lower in the mothers of preterm birth compared to non-preterm labor (term) group by using Terminal Restriction Fragment Length Polymorphism. A similar conclusion was found in another study. Cecilie Dahl et al. [19] found that mothers of preterm deliveries had a significantly lower abundance of Clostridium, including Ruminococcaceae, and Mogibacteriaceae, which agrees with our findings of a lower abundance of several OTUs from the Clostridiales order. Chunhua Yin et al. [20] found that patients with preterm birth were enriched with opportunistic pathogens, particularly Porphyromonas, Streptococcus, Fusobacterium, and Veillonella 16 S rRNA amplicon sequencing. We did not find enriched opportunistic pathogens in preterm mothers. The reason may be the different sampling times between studies. Chunhua Yin collected fecal samples in the middle of pregnancy. In contrast, we sampled the fecal of mothers in the last week before delivery, and it is well known that the composition of the gut microbiome will change in different periods of pregnancy.

We found that the gut of mothers delivering prematurely was lack of Lachnospiraceae, Ruminococcaceae, and Eubacteriaceae. These bacteria are abundant anaerobic bacteria of gut microbes, producing SCFA from dietary fiber degradation [25]. SCAFs are the primary energy source for colonocytes, which play an important role in improving gut barrier integrity, and regulating glucose and lipid metabolism as well as the immune system [26, 27]. Importantly, SFCAs inhibit LPS -induced inflammation through histone deacetylase and G-protein-coupled receptors [28, 29]. Besides, SFCAs process anti-inflammatory activities that regulate the expression of adhesion factors, pro-inflammatory cytokines, and chemokines [30, 31], such as tumor necrosis factor-α (TNF-α), IL-1β, IL-6, and IL-10 [32, 33]. Furthermore, SCFAs may be able to prevent myometrial contractions and rupture of membranes. The SCFAs butyrate and propionate suppressed inflammation-induced expression of the uterotonic prostaglandin PGF2alpha, myometrial cell contraction, and enzymes involved in remodeling myometrium and degradation of the fetal membranes [34].

Although many causes of PTB have been identified, accumulating evidence indicates that parturition is an inflammatory process [35]. PTB is firmly linked to inflammation regardless of infection [36]. Premature activation of the uterus by inflammation may lead to PTB, and IL-1 has been implicated in the cascade of events leading to PTB [37]. Multiple harmful factors stimulate the maternal innate immune response by activating Toll-like receptors, leading to the production of pro-inflammatory cytokines [38]. The cytokines subsequently activate gestational tissue, augment the contractility of the uterine, and drive cervical dilation and rupture of the fetal membrane [7, 34]. Animal experiments and human studies have shown that NLRP3 (NLR family pyrin domain-containing protein 3), caspase-1 (CASP-1), and IL-1 β were a high expression in amniotic fluid, amniotic membrane, and basement membrane detachment of premature mothers [39,40,41]. The IL-1β and TNF-α augment myometrial contractility by increasing calcium entry into myometrial smooth muscle cells [42]. In addition, as shown in mice, IL-1 administration induces PTB, inhibiting its receptor prevents labor [43]. An IL-1 receptor-associated kinase 1 (IRAK1) inhibitor significantly decreased PTB and increased live birth in WT mice [44]. The IL-1 receptor inhibitor, rytvela, may be of use in resolving inflammation associated with PTB and fetal injury [36, 45].

Inflammation is recognized as the major underlying cause of PTB, and SFCAs produced by Lachnospiraceae can inhibit inflammation through different signaling pathways. At the same time, the gut of mothers delivering prematurely shows a significant reduction of SFCAs-Producing microbiomes. The dysbiosis of the maternal gut microbiomes may affect fetal birth outcomes through microbiome-generated metabolites. Nickodem et al. [46] used plasma from 20 premature mothers and 30 healthy full-term mothers at the time of admission to labor and delivery to examine the maternal SFCAs to pregnancy outcome, founding that propionic acid in maternal plasma was negatively correlated with premature delivery. Although this is a pilot study, it provides an inspection to explore whether bacterial metabolites protect against inflammation pathways during pregnancy and reduce the incidence of PTB.

The present study has several limitations. First, the samples of preterm mothers were relatively small. When the sample sizes of two groups are significantly different, the efficacy of the t-test may be reduced. It may be more appropriate to use an alternative statistical method better equipped to handle uneven data, such as a non-parametric test like the Wilcoxon rank-sum test. Consequently, we implemented the Kruskal-Wallis test and the Wilcoxon rank-sum test for group comparisons. While these tests can partially mitigate the effects of sample size inequality, they cannot entirely eliminate the potential bias resulting from the imbalance. It is better to balance the sample sizes as much as possible. Secondly, we did not collect the dietary data. Although all the participants were from Chengdu (China), and generally show similar dietary habits, with a preference for spicy foods. It is known that dietary influences the gut microbiome. Therefore, it is important to collect and analyze dietary data in future studies.

So in the future, we plan to enroll a larger population to validate our findings. Secondly, we have observed that the mothers delivering preterm show a decrease of Lachnospiraceae which produces SFCAs. Therefore, we would like to explore whether this reduction of Lachnospiraceae corresponds to a decrease of SFCAs in the circulation of preterm mothers. At the same time, the dietary is an important factor, we will collect the dietary data of mothers to analyze the influence of dietary.


In summary, applying longitudinal sampling and whole-genome shotgun metagenomic analysis on 80 gut microbiotas of 43 mothers, we demonstrate that the disrupted gastrointestinal bacteria in mothers delivering prematurely, particularly the lack of Lachnospiraceae, predisposed fetus to the risk of PTB. This highlights the need for large-scale animal models to understand the impact of the maternal gut microbiome on newborn outcomes.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. The raw data have been submitted to China National GeneBank DataBase, CNGBdb (accession number, CNP0003746).



Preterm birth


Short fatty chain acids




Linear discriminate analysis effect size


IL-1 receptor-associated kinase 1

TNF- α:

Tumor necrosis factor-α




  1. Walani SR. Global burden of preterm birth. Int J Gynaecol Obstet. 2020;150(1):31–3.

    Article  PubMed  Google Scholar 

  2. Vogel JP, Chawanpaiboon S, Moller A-B, Watananirun K, Bonet M, Lumbiganon P. The global epidemiology of preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018;52.

  3. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027–35.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mericq V, Martinez-Aguayo A, Uauy R, Iñiguez G, Van der Steen M, Hokken-Koelega A. Long-term metabolic risk among children born premature or small for gestational age. Nat Rev Endocrinol. 2017;13(1):50–62.

    Article  CAS  PubMed  Google Scholar 

  5. Crump C, Sundquist J, Sundquist K. Risk of hypertension into adulthood in persons born prematurely: a national cohort study. Eur Heart J. 2020;41(16):1542–50.

    Article  PubMed  Google Scholar 

  6. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345(6198):760–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Nadeau-Vallée M, Obari D, Quiniou C, Lubell WD, Olson DM, Girard S, et al. A critical role of interleukin-1 in preterm labor. Cytokine Growth Factor Rev. 2016;28:37–51.

    Article  CAS  PubMed  Google Scholar 

  8. Couceiro J, Matos I, Mendes JJ, Baptista PV, Fernandes AR, Quintas A. Inflammatory factors, genetic variants, and predisposition for preterm birth. Clin Genet. 2021;100(4):357–67.

    Article  CAS  PubMed  Google Scholar 

  9. Nyangahu DD, Jaspan HB. Influence of maternal microbiota during pregnancy on infant immunity. Clin Exp Immunol. 2019;198(1):47–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ansari A, Bose S, You Y, Park S, Kim Y. Molecular mechanism of Microbiota Metabolites in Preterm Birth: pathological and therapeutic insights. Int J Mol Sci. 2021;22(15).

  11. Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019;220(4):324–35.

    Article  PubMed  Google Scholar 

  12. Figuero E, Han YW, Furuichi Y. Periodontal diseases and adverse pregnancy outcomes: mechanisms. Periodontol 2000. 2020;83(1):175–88.

    Article  PubMed  Google Scholar 

  13. Serrano MG, Parikh HI, Brooks JP, Edwards DJ, Arodz TJ, Edupuganti L, et al. Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy. Nat Med. 2019;25(6):1001–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fettweis JM, Serrano MG, Brooks JP, Edwards DJ, Girerd PH, Parikh HI, et al. The vaginal microbiome and preterm birth. Nat Med. 2019;25(6):1012–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chan D, Bennett PR, Lee YS, Kundu S, Teoh TG, Adan M, et al. Microbial-driven preterm labour involves crosstalk between the innate and adaptive immune response. Nat Commun. 2022;13(1):975.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bobetsis YA, Graziani F, Gürsoy M, Madianos PN. Periodontal disease and adverse pregnancy outcomes. Periodontol 2000. 2020;83(1):154–74.

    Article  PubMed  Google Scholar 

  17. Iheozor-Ejiofor Z, Middleton P, Esposito M, Glenny A-M. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst Rev. 2017;6:CD005297.

    Article  PubMed  Google Scholar 

  18. Shiozaki A, Yoneda S, Yoneda N, Yonezawa R, Matsubayashi T, Seo G, et al. Intestinal microbiota is different in women with preterm birth: results from terminal restriction fragment length polymorphism analysis. PLoS ONE. 2014;9(11):e111374.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dahl C, Stanislawski M, Iszatt N, Mandal S, Lozupone C, Clemente JC, et al. Gut microbiome of mothers delivering prematurely shows reduced diversity and lower relative abundance of Bifidobacterium and Streptococcus. PLoS ONE. 2017;12(10):e0184336.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yin C, Chen J, Wu X, Liu Y, He Q, Cao Y, et al. Preterm Birth is correlated with increased oral originated Microbiome in the gut. Front Cell Infect Microbiol. 2021;11:579766.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Boers SA, Jansen R, Hays JP. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory. Eur J Clin Microbiol Infect Dis. 2019;38(6):1059–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10.

  23. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30(21):3123–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sorbara MT, Littmann ER, Fontana E, Moody TU, Kohout CE, Gjonbalaj M, et al. Functional and genomic variation between human-derived Isolates of Lachnospiraceae reveals Inter- and intra-species diversity. Cell Host Microbe. 2020;28(1).

  26. Campos-Perez W, Martinez-Lopez E. Effects of short chain fatty acids on metabolic and inflammatory processes in human health. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(5):158900.

    Article  CAS  PubMed  Google Scholar 

  27. Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021;13(1).

  28. He J, Zhang P, Shen L, Niu L, Tan Y, Chen L, et al. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci. 2020;21(17).

  29. Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther. 2016;164:144–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Vinolo MAR, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3(10):858–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Liu T, Li J, Liu Y, Xiao N, Suo H, Xie K, et al. Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells. Inflammation. 2012;35(5):1676–84.

    Article  CAS  PubMed  Google Scholar 

  32. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111(6):2247–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ziętek M, Celewicz Z, Szczuko M. Short-chain fatty acids, maternal microbiota and metabolism in pregnancy. Nutrients. 2021;13(4).

  34. Moylan HEC, Nguyen-Ngo C, Lim R, Lappas M. The short-chain fatty acids butyrate and propionate protect against inflammation-induced activation of mediators involved in active labor: implications for preterm birth. Mol Hum Reprod. 2020;26(6):452–68.

    Article  CAS  PubMed  Google Scholar 

  35. Stelzer IA, Ghaemi MS, Han X, Ando K, Hédou JJ, Feyaerts D, et al. Integrated trajectories of the maternal metabolome, proteome, and immunome predict labor onset. Sci Transl Med. 2021;13(592).

  36. Nadeau-Vallée M, Quiniou C, Palacios J, Hou X, Erfani A, Madaan A, et al. Novel noncompetitive IL-1 receptor-biased ligand prevents infection- and Inflammation-Induced Preterm Birth. J Immunol. 2015;195(7):3402–15.

    Article  CAS  PubMed  Google Scholar 

  37. Nadeau-Vallée M, Chin P-Y, Belarbi L, Brien M-È, Pundir S, Berryer MH, et al. Antenatal suppression of IL-1 protects against Inflammation-Induced fetal Injury and improves neonatal and developmental outcomes in mice. J Immunol. 2017;198(5):2047–62.

    Article  CAS  PubMed  Google Scholar 

  38. Gillespie SL, Christian LM, Mackos AR, Nolan TS, Gondwe KW, Anderson CM, et al. Lifetime stressor exposure, systemic inflammation during pregnancy, and preterm birth among black american women. Brain Behav Immun. 2022;101:266–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Faro J, Romero R, Schwenkel G, Garcia-Flores V, Arenas-Hernandez M, Leng Y, et al. Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome†. Biol Reprod. 2019;100(5):1290–305.

    Article  PubMed  Google Scholar 

  40. Gomez-Lopez N, Romero R, Xu Y, Plazyo O, Unkel R, Leng Y, et al. A role for the inflammasome in spontaneous Preterm Labor with Acute histologic chorioamnionitis. Reprod Sci. 2017;24(10):1382–401.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Gomez-Lopez N, Romero R, Panaitescu B, Leng Y, Xu Y, Tarca AL, et al. Inflammasome activation during spontaneous preterm labor with intra-amniotic infection or sterile intra-amniotic inflammation. Am J Reprod Immunol. 2018;80(5):e13049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Tribe RM, Moriarty P, Dalrymple A, Hassoni AA, Poston L. Interleukin-1beta induces calcium transients and enhances basal and store operated calcium entry in human myometrial smooth muscle. Biol Reprod. 2003;68(5):1842–9.

    Article  CAS  PubMed  Google Scholar 

  43. Green ES, Arck PC. Pathogenesis of preterm birth: bidirectional inflammation in mother and fetus. Semin Immunopathol. 2020;42(4):413–29.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Jain VG, Kong F, Kallapur SG, Presicce P, Senthamaraikannnan P, Cappelletti M, et al. IRAK1 is a critical mediator of Inflammation-Induced Preterm Birth. J Immunol. 2020;204(10):2651–60.

    Article  CAS  PubMed  Google Scholar 

  45. Takahashi Y, Saito M, Usuda H, Takahashi T, Watanabe S, Hanita T, et al. Direct administration of the non-competitive interleukin-1 receptor antagonist rytvela transiently reduced intrauterine inflammation in an extremely preterm sheep model of chorioamnionitis. PLoS ONE. 2021;16(9):e0257847.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Nickodem CA, Menon R, McDonald T, Taylor BD. Circulating short-chain fatty acids in Preterm Birth: a pilot case-control study. Reprod Sci. 2020;27(5):1181–6.

    Article  CAS  PubMed  Google Scholar 

Download references


We thank all the participants in this study and all clinicians who were involved in the collection of fecal samples. We would like to thank the support of the Institutes for Systems Genetics in fecal DNA extraction. We would like to appreciate the Shenzhen Byoryn Technology, Northeast University, and Peking University Shenzhen Hospital for providing metagenomic data analysis. We would like to appreciate the West China Hospital Biomedical Big Data Center for providing servers.


This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations



RY collected fecal samples, extracted the DNA of samples, and drafted the manuscript; XYL collected fecal samples, extracted the DNA of samples; ZCZ, QYW and YNW performed data analysis; ZYY provided servers; BRS and WTP designed the cohort study, secured the funding, and provided supervision.

Corresponding authors

Correspondence to Bairong Shen or Wentao Peng.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Ethics approval and consent to participate

The study was approved by the Ethical Committee of the West China Second Hospital of Sichuan University (2021112). All methods were performed consistent with the relevant guidelines and regulations of the Declaration of Helsinki. Written informed consent was obtained from all patients for being included in the study.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, R., Li, X., Ying, Z. et al. Prematurely delivering mothers show reductions of lachnospiraceae in their gut microbiomes. BMC Microbiol 23, 169 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: